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Background: We aimed to report the results of percutaneous coronary intervention for chronic total
occlusion (CTO) in a remote hospital of southeast Taiwan that does not have on-site coronary artery
bypass graft support and has insufﬁcient medical resources.
Methods: From 2006 to 2009, we identiﬁed 96 patients who underwent percutaneous coronary inter-
vention and whose coronary angiogram showed CTO lesions. On-site cardiovascular surgeons were
unavailable from 2006 to 2009.
Results: The success rate (test for trend, p ¼ 0.02) and numbers of guidewires used (test for trend,
p ¼ 0.59) signiﬁcantly increased from 2006 to 2009, and the procedural time reduced signiﬁcantly (test
for trend, p ¼ 0.001). The volume of contrast media injected decreased, although this result was not
statistically signiﬁcant (p ¼ 0.70).
Conclusion: Our experience in managing CTO lesions substantially improved and the procedural time
reduced over 4 years, even when constrained by a relative shortage of medical resources.
Copyright © 2014, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Chronic total occlusion (CTO), which is a challenging clinical
condition treated using percutaneous coronary intervention (PCI)1,
has been associated with a high incidence of adverse cardiovascular
events2,3, a low procedural success rate4,5, and a high restenosis
rate6,7, as documented in previous studies of PCI. Recent clinical
trials have proved that successful interventions in such lesions are
associated with prolonged survival2,3 and improved left ventricular
(LV) function8,9, leading to myocardial electrical stability and
increased tolerance for future coronary events.
Restenosis rates associated with PCI have decreased remarkably
since the introduction of drug-eluting stents10e12. Recently, PCI
techniques for CTO have changed signiﬁcantly13,14 with the intro-
duction of parallel wiring and a retrograde approach. Manylare no conﬂicts of interest.
cular Division, Department of
ion 2, Chung San North Road,
hen).
tric Emergency & Critical Care Mepreviously used PCI techniques for CTO improved the success rate
but simultaneously prolonged potential radiation and procedural
time.
Taitung County, situated in southeast Taiwan, is characterized by
mountains and hills, which proves challenging for major trans-
portation and housing construction. Lower economic productivity,
low population density, and an aging population have led to
insufﬁcient or poorly accessible medical resources in this county.
This study analyzes the results of treatment of CTO in a catheteri-
zation room at the MackayMemorial Hospital (Taitung branch), the
largest hospital in Taitung. Medical resources and equipment were
restricted by health insurance policies; therefore, we desired an
optimal, simple, and cost-effective strategy for treating CTO lesions.2. Materials and methods
2.1. Participants
This study was conducted in accordance with the guidelines of
the Declaration of Helsinki and has received approval from the
Ethics Committee of Mackay Memorial Hospital (Taitung branch).dicine. Published by Elsevier Taiwan LLC. All rights reserved.
K.-T. Wang et al.158Of the 3037 consecutive patients referred for coronary catheteri-
zation from 2006 to 2009, 1798 patients underwent elective PCI.
From 2006 to 2009, we identiﬁed 96 patients who underwent PCI
and whose coronary angiogram showed CTO lesions. During this
period, on-site cardiovascular surgeons were unavailable at the
hospital. The indications for referral included ischemia docu-
mented either by resting electrocardiogram or stress testing, or
typical stable class II or III angina according to the Canadian Car-
diovascular Society. The demographic proﬁle, medical history,
coronary angiogram ﬁndings, number of guidewires used, PCI
procedural time, and contrast volume used in PCI were obtained
from the hospital registry. Patients were considered to have hy-
pertension (HTN) if they had a history of HTN or a systolic blood
pressure (BP) 140 mmHg or a diastolic BP of 90 mmHg. Patients
were considered to have diabetes mellitus (DM) if they had a his-
tory or a fasting blood glucose level 126 mg/dL. Moreover, pa-
tients were considered to have uremia if they were onmaintenance
hemodialysis. Complications included perforation of the coronary
artery, severe dissection (type C), no reﬂow after PCI, cardiac
tamponade, or shock during the PCI procedure performed with or
without an intra-aortic balloon pump or a coronary artery bypass
graft.
Stenotic coronary artery disease was deﬁned as the presence of
at least 50% stenosis of any of the major coronary arteries (left
anterior descending, left circumﬂex, or right coronary artery) or
their major branches (diagonal, obtuse marginal, posterior
descending, or posterior left ventricular)15. For the number of sig-
niﬁcant stenotic vessels, the occurrence of stenotic segments in one
of the major arteries or one of the major branches were estimated,
as visualized by two experienced cardiologists (K.T.W. and H.Y.C.). A
major branch was deﬁned as one in which the diameter was
2.5 mm. A CTO was deﬁned as an occlusion on angiography with
no antegrade ﬁlling of the distal vessel other than that via the
collaterals. The duration of the occlusion had to be >90 days, which
was estimated from the onset of clinical events such as myocardial
infarction (MI), sudden onset or worsening of the chest symptoms,
or proven by angiography. Coronary angiography was performed
using Philip Integris BH 5000 equipped with the CAAS II cardio-
vascular angiography analysis system (Pie Medical Imaging,
Maastricht, the Netherlands). The success rate of the treatment for
CTO lesion was deﬁned as a ﬁnal stenosis diameter of <50% on
quantitative coronary angiography. We treated all CTO lesions with
the antegrade approach and bare metal stent implantation.
2.2. Statistical analysis
Results are expressed as mean ± standard deviation or as per-
centages. Analysis of variance or Student’s t test was used for
continuous variables and the c2 test was used for categorical data to
compare differences between groups. A p value <0.05 was
considered statistically signiﬁcant. Multivariate logistic regression
model was performed to examine the independent factors associ-
ated with success CTO-PCI such as age (70 years vs. <70 years),
sex (men vs. women), HTN (yes vs. no), DM (yes vs. no), uremia (yes
vs. no), smoking status (yes vs. no), and statin (yes vs. no). All sta-
tistical analyses were performedwith SAS software version 9.0 (SAS
Institute, Cary, NC, USA).
3. Results
3.1. Patients, lesions, and procedural characteristics
Overall, 96 patients (age, 69.6 ± 12.2 years; male, 72.9%) with
CTO lesions underwent PCI from 2006 to 2009. Approximately
20e30 patients per year received treatment for CTO at our hospital,with a mean success rate of 73% (70 out of 96 patients). These pa-
tients received a sequential change of devices used from 2006
to2009. There were no signiﬁcant differences in age, sex, preva-
lence of HTN and DM, smoking status, history of uremia, previous
MI, approach site of PCI, and numbers of stenotic vessels from 2006
to 2009. The percentage of patients using angiotensin-converting
enzyme inhibitors or angiotensin receptor blockers, beta blockers,
or calcium-channel blockers was not different from 2006 to 2009,
but the percentage of statin use increased from 2006 to 2009
(Table 1). A high percentage of patients who underwent PCI in 2006
had previously undergone PCI and had total occlusion of the left
descending artery compared to those who underwent PCI in the
following 3 years. There were no signiﬁcant differences in age, sex,
prevalence of HTN and DM, smoking status, history of uremia,
previous MI and PCI, approach site of PCI, or the numbers of ste-
notic vessels between the successful and nonsuccessful groups. The
percentage of patients using angiotensin-converting enzyme in-
hibitors or angiotensin receptor blockers, beta blockers, or calcium-
channel blockers was not different between the successful and
nonsuccessful groups (Table 2). The procedural complication rate
was 3 (15.7%) in 2006, 3 (9.4%) in 2007, 0 (0%) in 2008, and 0 (0%) in
2009 (p ¼ 0.09). To further clarify the factors associated with the
success of CTO-PCI, the logistic regression model was performed
(Table 3). All patients with successful CTO-PCI were likely to be
aged >70 years [adjusted odds ratio (AOR), 1.49; 95% conﬁdence
interval (CI), 0.54e4.14]; other factors were DM (AOR, 1.24; 95% CI,
0.44e3.47), HTN (AOR,1.17; 95% CI, 0.37e3.72), uremia (AOR, 3.57
108; 95% CI, 0), and statin use (AOR, 1.46, 95% CI: 0.53e4.02), but
these factors did not reach statistic signiﬁcance.
3.2. Contrast volume, guidewire use, procedural time, and success
rate
The success rate (test for trend, p ¼ 0.02) and numbers of
guidewires used (test for trend, p ¼ 0.59) increased signiﬁcantly
from 2006 to 2009, and the procedural time reduced signiﬁcantly
(test for trend, p ¼ 0.001). The contrast volume injected decreased
from 2006 to 2009, although the difference was not statistically
signiﬁcant (test for trend, p ¼ 0.70) (Figs. 1 and 2). The mortality
rate in the successful and nonsuccessful groups was 6.7% and 4.8%
(p¼ 0.58), respectively, at 1 year follow-up. In the successful group,
three patients died because of noncardiac death and two patients
because of cardiac death. In the nonsuccessful group, one patient
died owing to cardiac death. Of the total, 47 patients (62.7%) in the
successful group received 1-year angiographic follow-up and 25
(53.2%) of 47 patients in the successful group underwent target
vessel revascularization.
4. Discussion
Our study results found an increased success rate for CTO le-
sions, decreased procedural time, and increased numbers of
guidewires in a consecutive series of patients from 2006 to 2009 in
a remote hospital. In our study, the success rate increased from 60%
in 2006 to 94.7% in 2009, and PCI-CTO became much safer from
2006 to 2009. The reasons for the increased success rate and
decreased procedural time might be related to operator volume,
operator experience, technique innovations, and well-trained staff.
The safety and effectiveness of more complex strategies are
related to operator volume and ascension of a learning curve16,17. It
is also important that a catheterization laboratory should have re-
sources to perform these complex procedures. Speciﬁcally, a well-
disciplined support staff is necessary to ensure familiarity with
infrequently used devices and to assist in the recognition and
management of complex lesions. Since the advent of better
Table 1
Demographic data of patients with chronic total occlusion who underwent percutaneous coronary intervention between 2006 and 2009.
Year group
2006 (n ¼ 19) 2007 (n ¼ 32) 2008 (n ¼ 26) 2009 (n ¼ 19) p
Age (y) 71.5 ± 9.5 65.3 ± 12.5 70.6 ± 12.9 73.4 ± 11.9 0.09
Sex (male) 15 (78.9) 23 (71.9) 18 (69.2) 14 (73.7) 0.91
HTN (yes) 16 (84.2) 20 (62.5) 22 (84.6) 14 (73.7) 0.19
DM (yes) 9 (47.4) 14 (43.8) 17 (65.4) 11 (57.9) 0.37
Smoking status (yes) 6 (31.6) 19 (59.4) 8 (30.8) 11 (57.9) 0.06
Uremia (yes) 1 (5.3) 4 (12.5) 0 (0) 3 (15.8) 0.19
Previous MI (yes) 5 (26.3) 5 (15.6) 3 (11.5) 1 (5.3) 0.30
Previous PCI (yes) 7 (36.8) 11 (34.4) 3 (11.5) 1 (5.3) 0.02
Medication
ACEI or ARB (yes) 14 (73.7) 22 (68.8) 19 (73.1) 10 (52.6) 0.45
Beta blocker (yes) 12 (63.2) 13 (40.6) 17 (65.4) 14 (73.7) 0.08
Statin (yes) 6 (31.6) 9 (28.1) 18 (69.2) 14 (73.7) 0.001
CCB (yes) 3 (15.8) 10 (31.3) 12 (46.2) 16 (31.6) 0.20
No. of stenotic CAD 0.91
Single 1 (5.3) 3 (9.4) 4 (15.4) 2 (10.5)
Double 4 (21.1) 4 (12.5) 5 (19.2) 3 (15.8)
Triple 14 (73.7) 25 (78.1) 17 (65.4) 14 (73.7)
CTO lesion location
LAD 11 (57.9) 10 (31.3) 6 (23.1) 3 (15.8) 0.03
LCX 1 (15.8) 10 (31.3) 4 (15.4) 6 (31.6) 0.35
RCA 7 (36.8) 16 (50.0) 16 (61.5) 10 (52.6) 0.44
Approach 0.37
Radial artery 16 (82.4) 23 (71.9) 17 (65.4) 10 (55.6)
Brachial artery 0 (0) 1 (3.1) 3 (11.5) 1 (5.6)
Femoral artery 3 (15.8) 8 (25.0) 6 (23.1) 7 (38.9)
Contralateral simultaneous injection 1 (5.3) 0 (0) 2 (7.7) 2 (10.5) 0.37
Data are presented as n (%) or mean ± SD.
ACEI ¼ angiotensin converting enzyme inhibitor; ARB ¼ angiotensin receptor blocker; CAD ¼ coronary artery disease; CCB ¼ calcium channel blocker; CTO ¼ chronic total
occlusion; DM ¼ diabetes mellitus; HTN ¼ hypertension; LAD ¼ left anterior descending; LCX ¼ left circumﬂex; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary
intervention; RCA ¼ right coronary artery.
CTO Without On-site Surgical Support 159guidewires, interventional cardiologists can successfully recanalize
CTO lesions18.
Procedural success may be achieved on the operators' persis-
tence. For all the procedures at our institute, we decided to mini-
mize procedural time. Therefore, there was no signiﬁcant
difference in procedural times between the successful and non-
successful groups.Table 2
Demographic data among successful and nonsuccessful CTO-PCI groups.
Successful
group (n ¼ 75)
Nonsuccessful
group (n ¼ 21)
p
Age (y) 70.0 ± 12.5 68.8 ± 12.4 0.89
Sex (male) 52 (69.3) 18 (85.7) 0.14
HTN (yes) 57 (76.0) 15 (71.4) 0.67
DM (yes) 42 (56.0) 9 (42.9) 0.29
Smoking status (yes) 33 (44.0) 11 (52.4) 0.99
Uremia (yes) 8 (10.7) 0 (0) 0.12
Previous MI (yes) 11 (14.7) 3 (14.3) 0.97
Previous PCI (yes) 18 (24.0) 4 (19.0) 0.63
Procedural time 104.5 ± 39.7 96.9 ± 401 0.45
Medication
ACEI or ARB (yes) 51 (68.0) 14 (66.7) 0.91
Beta blocker (yes) 45 (60.0) 11 (52.4) 0.53
Statin (yes) 38 (50.7) 9 (42.9) 0.53
CCB (yes) 23 (30.7) 8 (38.1) 0.52
No. of stenotic CAD 0.58
Single 8 (10.7) 2 (9.5)
Double 14 (18.7) 2 (9.5)
Triple 53 (70.7) 17 (81.0)
CTO lesion location
LAD 25 (33.3) 5 (23.8) 0.41
LCX 17 (22.7) 6 (28.6) 0.58
RCA 39 (52.0) 10 (47.6) 0.72
Mortality at 1-year follow-up 5 (6.7) 1 (4.8) 0.58
Data are presented as n (%) or mean ± SD.
Abbreviations as in Table 1.4.1. Historical reviews of CTO success rate
In a single-center, 25-year study from the Mayo Clinic, the
procedural success rate for CTO-PCI in the pre-stent era between
1979 and 1989 was only 51%.5 After the introduction of stents, the
CTO-PCI success rate increased to 70e72% in the bare-metal stent
era and reached approximately 70% in the drug-eluting stent era.
The CTO New techniQUE for Standard procedure (CONQUEST)
registry was conducted by the CTO “specialized” operators at six
Japanese centers, and the success rate was 86.2%13. The J-CTO
registry (a multicenter CTO registry in Japan) reported that a suc-
cess rate of 86.6% and reduced contrast volume compared with
those obtained in the CONQUEST study19. Contemporary experi-
ences in the United States and Europe have shown technical success
rates of approximately 90% and 83.4%, respectively, using the
retrograde approach.16,17 Although the success rate for CTO lesions
from our study was initially lower, it reached approximately 94.7%
over 3 years. Our success rate ﬁnally reached 80e90% and was
comparable to the results of the abovementioned studies.Table 3
Contributions of variables to success in chronic coronary total occlusione percuta-
neous coronary intervention.
Variables Odds ratio (95% CI) p
Age (70 y vs. <70 y) 1.49 (0.54e4.14) 0.45
Sex (men vs. women) 2.07 (0.48e8.88) 0.33
HTN (yes vs. no) 1.17 (0.37e3.72) 0.79
DM (yes vs. no) 1.24 (0.44e3.47) 0.68
Smoking (yes vs. no) 1.05 (0.35e3.13) 0.93
Uremia (yes vs. no) 3.57  108 (0e) 1.00
Statin (yes vs. no) 1.46 (0.53e4.02) 0.47
Abbreviations as in Table 1.
CI ¼ conﬁdence interval.
Fig. 1. The number of guidewires used for chronic total occlusion from 2006 to 2009.
Guidewire (GW)1 including Runthrough (Terumo), Rinato (Asahi), Fielder FC (Asahi),
Whisper (Guidant), Runthrough NS intermediate (Terumo) and CROSS-IT XT (Abbott
vascular). GW2 including Miracle 3-5g (Asahi), Conquest pro 9 (Asahi), Conquest pro
12 (Asahi) and Conquest pro 20 (Asahi). Total GW number ¼ GW1 numberþGW2
number. Test for trends in GW1, GW2, and total GW: p ¼ 0.42, p ¼ 0.77, and p ¼ 0.59,
respectively.
Fig. 2. Contrast volume, procedural time, and success rate from 2006 to 2009. Test for
trends in the contrast volume, procedure time, and success rate: p ¼ 0.70, p ¼ 0.001,
and p ¼ 0.02, respectively.
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common location of the CTO, whereas this percentage was 44.3% in
the J-CTO registry19 and 41.7% in a meta-analysis of 65 studies20.
The prevalence of HTN in our study was higher than that noted in
the J-CTO registry19 or the Mayo Clinic study5. The prevalence of
DM in our study was higher than that in the CONQUEST registry13.
The percentage of triple-vessel disease was higher in our study
(72.9%) than that in the CONQUEST registry, J-CTO registry, or the
Mayo Clinic study (17.3%, 22.7%, or 30.8%, respectively)5,13,19. In a
meta-analysis of 13 observational studies, multivessel disease,
location of CTO, cardiovascular factors such as age, sex, and renal
dysfunction, and DM were not associated with CTO-PCI success20.
Our study also had similar results.
4.2. Current status of PCI-CTO
The potential disadvantages of PCI-CTO are long procedural
time, long ﬂuoroscopic time, and a high contrast volume. In our
study, we reduced the procedural time and the contrast volume.
Decreased procedural time could avoid skin injury due to radiation.
Suzuki et al21 have shown that limiting the total ﬂuoroscopic timeor dose-area product or changing the beam angulation is important
for controlling the skin dose during prolonged procedures.
Contrast-induced nephropathy was one of the serious adverse ef-
fects in complex PCI. We attempted to adjust the contrast volume
based on preoperative renal function and minimize the volume
used in this study. However, it is necessary that continuous efforts
be made to further decrease the procedural time and contrast
volume.
4.3. Follow-up and clinical implications
In the successful group of our study, two patients (2.6%) died
because of cardiac death 1 year after PCI. However, in a previous
meta-analysis, 77 deaths were reported after PCI, with mortality
rates ranging from 0% to 3.6%22. In addition, 53.2% of angiographic
follow-up patients underwent target vessel revascularization,
which is 23.95% of bare metal stent-treated patients and 11.71% of
drug-eluting stent-treated patients in the meta-analysis study23.
Several observational studies have shown a survival beneﬁt when
CTO is successfully treated compared to that when the vessel is not
opened4,5,24. Other studies have shown an improvement in regional
and global left ventricular function after treatment, with a decrease
in end-systolic volume and an increase in ejection fraction8,9.
Therefore, recanalization of coronary CTO may be associated with
favorable long-term outcomes and better cardiac function. In our
study, the rate of procedural complications decreased, whereas the
rate of procedural success increased from 2006 to 2009. Therefore,
CTO for PCI carries a low risk for procedural complications and
results in high success rates.
Therewere several limitations in this study. First, this study is an
observational study, and the study design did not involve
randomization. Some unobserved characteristics may be sources of
residual confounders. The nonrandomized nature of this study did
not allow prediction of the precise success rate of PCI-CTO. Further
research is needed to clarify these potential effects. Second, the
number of operators at this remote hospital was limited during the
duration of the study. Our experience might be applied to other
hospitals without on-site surgical support. Third, the small sample
size limited the power of the statistical analyses in this study.
Fourth, we cannot analyze predictors related to success rate and
revascularization rate in our dataset. However, all CTO-PCI pro-
cedures were performed or supervised by K.T.W.. The introduction
of new PCI techniques for CTO that combine different strategies
such as the use of contralateral injections or dissection/reentry
techniques coupled with dedicated, high-volume CTO PCI operators
may play a role in improving success rates.
5. Conclusion
The success rate of PCI for CTO can be increased using
contemporary strategies and techniques by experienced cardiolo-
gists with a safety proﬁle compared to that of standard risk-
adjusted PCI. Our experience in managing CTO lesions in Taitung
County showed substantial improvements over the years, as well as
a shortened procedural time even when constrained by a relative
shortage of medical resources. Information regarding the cost-
effectiveness of such a challenging intervention may need to be
clariﬁed in the future.
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